August 16-17, 2022 | Philadelphia, PA
www.informaconnect.com/IDN
Don’t miss the IDN & Bio/Pharma Partnering Summit coming up this summer in Philadelphia, where you'll be part of the important discussions on how to best optimize strategic partnerships to improve patient access and outcomes. This event showcases novel case studies and in-depth sessions that focus on innovative partnership models that will aid in delivering enhanced value, manageable costs and high-quality results.
Visit www.informaconnect.com/IDN for further details and to register. Drug Channels readers will save 10% off when they use code 22DRCH10 and register prior to June 31, 2022.*
The 2022 format includes 2 days of in-person programming, plus a virtual offering of select sessions and recorded presentations available on-demand for 12 months following the conference. Both the in-person and virtual options will include networking opportunities to connect with industry peers and colleagues.
The Summit features coverage on the hottest topics impacting you today, from speakers representing Atrium Health, Bayer, Cone Health, CSL Behring, Fairview Health Services, Nebraska Medicine, NYU Langone Health System, Pfizer, Quil Health, Tempus Labs, TG Therapeutics, University of California, Davis, University of Illinois at Chicago, College of Pharmacy, University of Pennsylvania Health System, Vanderbilt Specialty Pharmacy and Vifor Pharma.
View the agenda to see the complete picture – the program, speakers, and more!
Visit www.informaconnect.com/IDN for further details and to register. Drug Channels readers will save 10% off when they use code 22DRCH10 and register prior to June 31, 2022.*
*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates or other offers. Other restrictions may apply.
The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@drugchannels.net).
No comments:
Post a Comment